CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Donlar Biosyntrex Corp. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Donlar Biosyntrex Corp.
6502 South Archer Road
Phone: (708) 563-9200p:708 563-9200 Bedford Park, IL  60501  United States Fax: (708) 563-9220f:708 563-9220
This company no longer files statements with the SEC.
Business Summary
Donlar Biosyntrex Corp. (Biosyntrex) conducts its business through three product lines BioPolymers, consisting of the performance chemicals business acquired from Donlar; AgriSciences, consisting of the agricultural business acquired from Donlar, and Optim Nutrition, consisting of Biosyntrex's nutritional and nutraceuticals business. In transactions closing in November 2000 and January 2001, the Company, then know as Biomune Systems, Inc., acquired the business of Donlar Corp. (Donlar), which is the manufacturing and marketing of agricultural, industrial and consumer products. Donlar also transferred to Biosyntrex all technology, know how and patents for the crop nutrient management and oil field services businesses created after November 3, 2000, as well as all technology resulting from Donlar pharmaceutical research and development activities after November 3, 2000. The Company's business is the production and marketing of products initially developed by Donlar.
(Source: 10KSB)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20009/30/2000Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8731 Commercial physical and biological research
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer Larry P.Koskan 57 11/3/2000 11/3/2000
Vice President Robert P.Pietrangelo 61 11/3/2000 11/3/2000
Vice President Joseph F.Prochaska 54 11/3/2000 11/3/2000
Treasurer, Controller Joel H.Lurquin 36 11/3/2000 11/3/2000

General Information
Number of Employees: 5 (As of 12/31/2000)
Outstanding Shares: 42,999,500 (As of 1/4/2001)
Shareholders: 5,292
Stock Exchange: OTC
Federal Tax Id: 870380088
Fax Number: (708) 563-9220


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023